The residual risk challenge in CVD: How important are triglycerides?

10' education - Sep. 25, 2020 - Prof. Ulf Landmesser, MD - Berlin, Germany

Video navigation menu

Residual risk challenge in ASCVD 01:13
Causal pathways in ASCVD 03:40
Genetic studies, lipoproteins and ASCVD 07:05
Role of triglyceride-rich lipoproteins 09:06
Summary 12:16

Educational information

This lecture by prof. Ulf Landmesser was part of an accredited symposium "Novel opportunities tackling residual cardiovascular risk: The evolving role of triglycerides" held during the virtual ESC Congress 2020.

Faculty

Prof. Ulf Landmesser, MD, cardiologist, Charité-Universitätsmedizin Berlin, Germany.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Amarin.

Click here for the meeting report View slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.